CERAVER, a pioneer in orthopaedics
CERAVER, a former subsidiary of the Alcatel-Alsthom group, began its activity in orthopaedics thanks to the chance meeting of a materials engineer, Daniel BLANQUAERT, and an orthopaedic surgeon, Pierre BOUTIN. This meeting marked the start of a series of innovations that would revolutionise the world of hip replacement orthopaedics. This is how the invention of the alumina-alumina articulation total hip prosthesis came about, along with discovering the significant potential of titanium alloy TiAl6V4.
A few significant CERAVER dates
First tests on Al2O3 – Al2O3 articulation : Biology, tribology.
Dr Pierre Boutin performed the world’s first total hip prosthesis with an alumina-alumina articulation. This component presents very low wear and friction characteristics – essential parameters in the design of joint prostheses. Perfectly biotolerant, this component went on to become the reference for articulations.
Discovery of the potential of the titanium alloy TiAl6V4 by Daniel Blanquaert.
Dr Pierre Boutin performed the world’s first implantation of a hip with a femoral stem made of titanium alloy TiAl6V4. This material went on to become the reference and is universally used in orthopaedics.
First cementless straight stem.
World’s first implant of a cement-free metal cup in titanium alloy for a hip prosthesis with an alumina ceramic core, a solution subsequently adopted by all the world’s major laboratories.
Concept of fixed bearing posterior stabilised knee prosthesis created.
First studies on an anti-bacterial coating.
Initial work on use of bone substitutes in cell therapy.
First ULYS implant for fracture using endo-ancillary instruments.
First biomimetic bone repair implants.
Europeen patent CERACAGE for cervical rachis.
Europeen patent CERADISC for cervical rachis.
ANSM autorisation for a clinical study on the anti-bacterial adhesion coating ACTISURF
First implantation of stems and cups CERAFIT coated with ACTISURF